Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 64 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Συντάκτης is Papadopoulos, C  [Clear All Filters]
2020
Patoulias, D., & Papadopoulos C. (2020).  Acute heart failure, type 2 diabetes and loop diuretic use: any adjunct role for sodium-glucose cotransporter-2 inhibitors?.
Gkantaifi, A., & Papadopoulos C. (2020).  Evaluation of the irradiated volume of the heart and cardiac substructures after left breast radiotherapy.
Patoulias, D., & Papadopoulos C. (2020).  Glucagon-like peptide-1 receptor agonists or sodium–glucose cotransporter-2 inhibitors as add-on therapy for patients with type 2 diabetes? A systematic review and meta-analysis of surrogate metabolic endpoints.
Bakogiannis, K., & Papadopoulos C. (2020).  Iron deficiency as therapeutic target in heart failure: a translational approach.
Mouselimis, D., Tsarouchas A., & Papadopoulos C. (2020).  Left atrial strain, intervendor variability, and atrial fibrillation recurrence after catheter ablation: A systematic review and meta-analysis.
Loutradis, C., Papadopoulos C., & Sarafidis P. (2020).  Longer dialysis sessions improve cardiac systolic function by reducing myocardial stunning.
Loutradis, C., & Papadopoulos C. (2020).  Lung Ultrasound–Guided Dry Weight Assessment and Echocardiographic Measures in Hypertensive Hemodialysis Patients: A Randomized Controlled Study.
Patoulias, D., & Papadopoulos C. (2020).  Meta-Analysis Assessing the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors According to Baseline Treatment of Interest.
Papadopoulos, C. (2020).  Meta-analysis Assessing the Effect of Sodium-Glucose Co-transporter-2 Inhibitors on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus.
Patoulias, D., & Papadopoulos C. (2020).  Meta-Analysis Assessing the Effects of Allopurinol on Left Ventricular Mass and Other Indices of Left Ventricular Remodeling as Evaluated by Cardiac Magnetic Resonance Imaging..
Patoulias, D., & Papadopoulos C. (2020).  Meta-analysis Evaluating the Risk of Atrial Fibrillation With Newer Antidiabetics Across the Cardiovascular and Renal Outcome Trials.
Patoulias, D., & Papadopoulos C. (2020).  Meta-analysis of Dedicated Renal Outcome Trials Assessing the Cardio-renal Efficacy of Sodium-Glucose Co-transporter-2 Inhibitors in Patients With Chronic Kidney Disease and Albuminuria.
Patoulias, D., & Papadopoulos C. (2020).  Pericardial fat in type 2 diabetes: not just a biomarker, but a promising treatment target?.
Papademetriou, V., & Papadopoulos C. (2020).  Pharmacological management of diabetic nephropathy.
Patoulias, D., & Papadopoulos C. (2020).  Postdischarge antidiabetic treatment in patients with type 2 diabetes and acute coronary syndrome: Time for a change?.
Patoulias, D., & Papadopoulos C. (2020).  Postdischarge antidiabetic treatment in patients with type 2 diabetes and acute coronary syndrome: Time for a change?.
Patoulias, D., & Papadopoulos C. (2020).  Prognostic value of arterial stiffness measurements in cardiovascular disease, diabetes, and its complications: The potential role of sodium-glucose co-transporter-2 inhibitors.
Tzikas, S., & Papadopoulos C. (2020).  A proposal for implementation of the chest pain unit model in Greece.
Patoulias, D., & Papadopoulos C. (2020).  Sodium-glucose co-transporter-2 inhibitors, cardiovascular outcomes and the impact of gender: Class effect or statistical play of chance?.
Patoulias, D., & Papadopoulos C. (2020).  Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions.
Boulmpou, A., Kassimis G., & Papadopoulos C. (2020).  Spontaneous coronary artery dissection (SCAD): Case series and mini review.
Tsarouchas, A., & Papadopoulos C. (2020).  Spontaneous Epidural Hematoma of the Cervical Spine Following Thrombolysis in a Patient with STEMI-Two Medical Specialties Facing a Rare Dilemma.
Patoulias, D., & Papadopoulos C. (2020).  Time to assess the effects of sodium–glucose co-transporter-2 inhibitors on the ‘forgotten' right ventricle?.
Patoulias, D., & Papadopoulos C. (2020).  Updated Meta-analysis Assessing the Effect of Sodium-Glucose Co-transporter-2 Inhibitors on Surrogate End points in Patients With Heart Failure With Reduced Ejection Fraction.
Patoulias, D., & Papadopoulos C. (2020).  Updated Meta-Analysis of Trials Assessing the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Black Patients.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.